Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.

about

Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.

Item

http://www.wikidata.org/entity/Q55398190

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Meglumine antimoniate intrales ...... abel, phase II clinical trial.

@en

Meglumine antimoniate intrales ...... abel, phase II clinical trial.

@nl

type

Item

label

Meglumine antimoniate intrales ...... abel, phase II clinical trial.

@en

Meglumine antimoniate intrales ...... abel, phase II clinical trial.

@nl

prefLabel

Meglumine antimoniate intrales ...... abel, phase II clinical trial.

@en

Meglumine antimoniate intrales ...... abel, phase II clinical trial.

@nl

P1476

Meglumine antimoniate intrales ...... label, phase II clinical trial

@en

P2093

Ana Rabello

http://www.w3.org/2001/XMLSchema#string

Dario Brock Ramalho

http://www.w3.org/2001/XMLSchema#string

Gláucia Cota

http://www.w3.org/2001/XMLSchema#string

Hugo Silva Assis Moreira

http://www.w3.org/2001/XMLSchema#string

Lara Saraiva

http://www.w3.org/2001/XMLSchema#string

Maria Camilo Ribeiro de Senna

http://www.w3.org/2001/XMLSchema#string

Mariana Junqueira Pedras

http://www.w3.org/2001/XMLSchema#string

Rosiana Estéfane da Silva

http://www.w3.org/2001/XMLSchema#string

P2860

The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.

Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).

Intralesional Pentamidine: A Novel Therapy for Single Lesions of Bolivian Cutaneous Leishmaniasis

Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre

Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil.

Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.

P304

e180200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/0074-02760180200

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Daniel M Avelar

P577

2018-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29947651

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

6012678

http://www.w3.org/2001/XMLSchema#string